Cisco joins other tech giants by emphasizing fertility, adoption benefits

Cisco is getting a lot more family-friendly in 2019.

The tech giant is rolling out egg storage reimbursement, surrogacy reimbursement and genetic testing benefits for its 38,000 U.S. employees — following the lead of other employers that are ramping up family-oriented perks to attract and retain talent.

The hunt is particularly apparent in Silicon Valley — Cisco is headquartered in San Jose, California — where tech companies are among those leading the way in progressive family benefits. Facebook, for example, provides employees up to four IVF cycles, including genetic testing, with no preapproval required. The social media giant also offers egg freezing; Apple does the same for its employees.

Cisco says it will reimburse employees up to $20,000 to harvest or store eggs or embryos and support pregnancy-fostering services. It also will increase reimbursement for adoption and surrogacy to $20,000 in 2019 from $10,000 now, and will cover genetic testing to identify gene changes associated with breast and ovarian cancer, even if the test is not medically necessary. The changes, announced in tandem with open enrollment, will kick in Jan. 1.

Cisco.Bloomberg.jpg
Pedestrians walk past the Cisco Systems Inc. sign outside of their Headquarters in San Jose, California, U.S., on Tuesday, June 12, 2011. Cisco Systems Inc., the largest networking-equipment company, may cut as many as 10.000 jobs, or about 14 percent of its workforce, to revive profit growth, according to two people familiar with plans. Photographer: David Paul Morris/Bloomberg *** Local Caption ***

The company’s benefits enhancements “support diverse needs at every life stage for all employees and their families,” says Karen Wiens, HR director of health and wellness strategy at Cisco. “We want to adapt our benefits to the generations, especially as [they relate] to the choice of having children later in life and evolving technology that encourages prevention and medical interventions to address the risk.”

Fertility benefits and adoption benefits have been growing in recent years. According to research from Willis Towers Watson, the percentage of employers offering fertility benefits to employees is expected to grow to 66% by 2019 from 55% in 2017.

“Employers are evolving their healthcare programs to reflect that fertility benefits are becoming more important to many employees, including same-sex couples,” Jeff Levin-Scherz, a Willis Towers Watson researcher, told EBN earlier this year. “The additional coverage is often a win-win proposition. It allows employers to provide a valued employee benefit while improving their ability to attract and retain top talent and support diversity initiatives.”

Cisco joins several other companies that have recently added or increased fertility benefits. State Street announced $20,000 in reimbursement for expenses related to certain fertility expenses, such as surrogacy, beyond what is offered through the firm’s medical plans. American Express bumped its fertility coverage to $35,000 from $20,000, last year while Pinterest increased its fertility coverage to $20,000 from $5,000.

Genetic testing, however, is a less-common benefit offering. Roughly 18% of employers offer genetic testing as part of their health coverage, according to the Society for Human Resource Management, but industry insiders say that number is expected to rise.

“We wanted to lead the market by offering this genetic test without medical necessity, within our medical plans, to enable informed decision-making to address a significant cancer risk,” Wiens says.

Under Cisco’s benefit, genetic tests are covered in full by the company as part of preventive health screenings available within its self-insured medical plans.

“All it takes is a conversation between the patient and physician in order to start the process of recommended pre-test counseling and ordering of the test,” she explains.

See also: 4 reasons employers should pay attention to genetic testing

“When test results are positive, there is a significant risk of developing breast and/or ovarian cancer and there are medically recommended interventions to address the risk,” Wiens notes.

For reprint and licensing requests for this article, click here.